Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 43, Issue 4, 2014, Pages 1375-1392

  Monteiro Cardoso, Vera F ^a   Oliveira, M Manuel ^a   Melo, Tânia ^b   Domingues, Maria R M ^b   Moreira, Paula I ^c,d   Ferreiro, Elisabete ^d,e   Peixoto, Francisco ^f   Videira, Romeu A ^a  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

^f UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Alzheimer's disease; brain bioenergetics; cardiolipin; mitochondrial lipidomics

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CARDIOLIPIN; ETHANOLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PLASMALOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; BRAIN MITOCHONDRION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; LIPIDOMICS; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; SYNAPTIC MEMBRANE; 129 MOUSE; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SYNAPSE; TRANSGENIC MOUSE;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BRAIN; CARDIOLIPINS; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PHOSPHOLIPIDS; PHOSPHORYLATION; SYNAPSES;

EID: 84919926803     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141002     Document Type: Article

References (60)

1. Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M (2008) Informatics and computational strategies for the study of lipids. Mol Biosyst 4, 121-127.
2. van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: Where they are and how they behave. Nat Rev Mol Cell Biol 9, 112-124.
3. Moller DE, Kaufman KD (2005) Metabolic syndrome: A clinical and molecular perspective. Annu Rev Med 56, 45-62.
4. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu Rev Genet 39, 359-407.
5. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189.
6. Contestabile A (2011) The history of the cholinergic hypothesis. Behav Brain Res 221, 334-340.
7. LaFerlaFM(2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3, 862-872.
8. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer's disease: The cholesterol connection. Nat Neurosci 6, 345-351.
9. Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics. Nat Rev Drug Discov 10, 698-712.
10. Arispe N, Diaz JC, Simakova O (2007) Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers. Biochim Biophys Acta 1768, 1952-1965.
11. Hattori C, Asai M, Onishi H, Sasagawa N, Hashimoto Y, Saido TC, Maruyama K, Mizutani S, Ishiura S (2006) BACE1 interacts with lipid raft proteins. J Neurosci Res 84, 912-917.
12. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46, 860-866.
13. Aleardi AM, Benard G, Augereau O, Malgat M, Talbot JC, Mazat JP, Letellier T, Dachary-Prigent J, Solaini GC, Rossignol R (2005) Gradual alteration of mitochondrial structure and function by beta-amyloids: Importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr 37, 207-225.
14. Swerdlow RH, Khan SM (2004) A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med Hypotheses 63, 8-20.
15. Swerdlow RH, Burns JM, Khan SM (2010) The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 20(Suppl 2), S265-S279.
16. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G (2010) Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta 1802, 2-10.
17. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, OliveiraCR(2008) Brain oxidative stress in a tripletransgenic mouse model of Alzheimer disease. Free Radic Biol Med 44, 2051-2057.
18. Schwall CT, Greenwood VL, Alder NN (2012) The stability and activity of respiratory Complex II is cardiolipindependent. Biochim Biophys Acta 1817, 1588-1596.
19. Melo T, Videira RA, Andre S, Maciel E, Francisco CS, Oliveira-Campos AM, Rodrigues LM, Domingues MR, Peixoto F, Manuel Oliveira M (2012) Tacrine and its analogues impair mitochondrial function and bioenergetics: A lipidomic analysis in rat brain. J Neurochem 120, 998-1013.
20. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN (2008) Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: Lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 49, 2545-2556.
21. Osman C,Voelker DR, Langer T (2011) Making heads or tails of phospholipids in mitochondria. J Cell Biol 192, 7-16.
22. Zhang M, Mileykovskaya E, Dowhan W (2002) Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277, 43553-43556.
23. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070.
24. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
25. Hammer DF, Unverferth DV, Kelley RE, Harvan PA, Altschuld RA (1988) Extraction and measurement of myocardial nucleotides, nucleosides, and purine bases by high-performance liquid chromatography. Anal Biochem 169, 300-305.
26. Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177, 751-766.
27. Spitz DR, Oberley LW(1989) An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 179, 8-18.
28. Del Rio LA, Ortega MG, Lopez AL, Gorge JL (1977) A more sensitive modification of the catalase assay with the Clark oxygen electrode. Application to the kinetic study of the pea leaf enzyme. Anal Biochem 80, 409-415.
29. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74, 214-226.
30. Lima FD, Stamm DN, Della-Pace ID, Dobrachinski F, de Carvalho NR, Royes LF, Soares FA, Rocha JB, Gonzalez-Gallego J, Bresciani G (2013) Swimming training induces liver mitochondrial adaptations to oxidative stress in rats submitted to repeated exhaustive swimming bouts. PLoS One 8, e55668.
31. Menassol JB, Tautou C, Collet A, Chesneau D, Lomet D, Dupont J, Malpaux B, Scaramuzzi RJ (2011) The effect of an intracerebroventricular injection of metformin or AICAR on the plasma concentrations of melatonin in the ewe: Potential involvement of AMPK? BMC Neurosci 12, 76.
32. KiebishMA,Han X, Cheng H, Lunceford A, ClarkeCF,Moon H, Chuang JH, Seyfried TN (2008) Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J Neurochem 106, 299-312.
33. Monteiro-Cardoso VF, Silva AM, Oliveira MM, Peixoto F, Videira RA (2014) Membrane lipid profile alterations are associated with the metabolic adaptation of the Caco-2 cells to aglycemic nutritional condition. J Bioenerg Biomembr 46, 45-57.
34. Madeira VM, Antunes-Madeira MC, Carvalho AP (1974) Activation energies of the ATPase activity of sarcoplasmic reticulum. Biochem Biophys Res Commun 58, 897-904.
35. Bartlett EM, Lewis DH (1970) Spectrophotometric determination of phosphate esters in the presence and absence of orthophosphate. Anal Biochem 36, 159-167.
36. Doria ML, Cotrim Z, Macedo B, Simoes C, Domingues P, Helguero L, Domingues MR (2012) Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells. Breast Cancer Res Treat 133, 635-648.
37. Ding F, Yao J, Rettberg JR, Chen S, Brinton RD (2013) Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: Implication for bioenergetic intervention. PLoS One 8, e79977.
38. Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B,Wisniewski T, de Leon MJ (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging 36, 811-822.
39. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, KuhlDE(1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42, 85-94.
40. Iglesias-Gonzalez J, Sanchez-Iglesias S, Beiras-Iglesias A, Soto-Otero R, Mendez-Alvarez E (2013) A simple method for isolating rat brain mitochondria with high metabolic activity: Effects of EDTA and EGTA. J Neurosci Methods 213, 39-42.
41. Gellerich FN, Deschauer M, Chen Y, Muller T, Neudecker S, Zierz S (2002) Mitochondrial respiratory rates and activities of respiratory chain complexes correlate linearly with heteroplasmy of deleted mtDNA without threshold and independently of deletion size. Biochim Biophys Acta 1556, 41-52.
42. Monteiro-Cardoso VF, Olivera MM, Peixot F, Videira RA (2013) Brain synaptic mitochondria dysfunction: An early event in triple-transgenic mice model of Alzheimer's disease. Eur J Clin Invest 43 44-44.
43. Chicco AJ, Sparagna GC (2007) Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 292, C33-C44.
44. Claypool SM (2009) Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim Biophys Acta 1788, 2059-2068.
45. Boumezbeur F, Mason GF, de Graaf RA, Behar KL, Cline GW, Shulman GI, Rothman DL, Petersen KF (2010) Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy. J Cereb Blood Flow Metab 30, 211-221.
46. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 107, 18670-18675.
47. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S (2009) AMPK in the brain: Its roles in energy balance and neuroprotection. J Neurochem 109(Suppl 1), 17-23.
48. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 106, 14670-14675.
49. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age inADtransgenic mice. Neurobiol Aging 30, 1574-1586.
50. Blass JP, Sheu RK, Gibson GE (2000) Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. AnnNY Acad Sci 903, 204-221.
51. Schwarz TL (2013) Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol 5, pii: a011304.
52. FrisardiV, Panza F, Seripa D, Farooqui T, FarooquiAA(2011) Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer's disease pathology. Prog Lipid Res 50, 313-330.
53. Sundaram JR, Chan ES, Poore CP, Pareek TK, Cheong WF, Shui G, Tang N, Low CM, Wenk MR, Kesavapany S (2012) Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J Neurosci 32, 1020-1034.
54. Kuczynski B, Reo NV (2006) Evidence that plasmalogen is protective against oxidative stress in the rat brain. Neurochem Res 31, 639-656.
55. Farooqui AA, Rapoport SI, Horrocks LA (1997) Membrane phospholipid alterations in Alzheimer's disease: Deficiency of ethanolamine plasmalogens. Neurochem Res 22, 523-527.
56. Hauff KD, Hatch GM (2006) Cardiolipin metabolism and Barth Syndrome. Prog Lipid Res 45, 91-101.
57. Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, Tyurin VA, Yanamala N, Shrivastava IH, Mohammadyani D, Qiang Wang KZ, Zhu J, Klein-Seetharaman J, Balasubramanian K, Amoscato AA, Borisenko G, Huang Z, Gusdon AM, Cheikhi A, Steer EK, Wang R, Baty C, Watkins S, Bahar I, Bayir H, Kagan VE (2013) Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol 15, 1197-1205.
58. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJ (2002) Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51, 634-637.
59. Acehan D, Vaz F, Houtkooper RH, James J, Moore V, TokunagaC, KulikW,Wansapura J,Toth MJ, Strauss A, KhuchuaZ (2011) Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem 286, 899-908.
60. Paradies G, Petrosillo G, Ruggiero FM (1997) Cardiolipindependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim Biophys Acta 1319, 5-8.